drugset / Trial / NCT07689162

Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia

NCT07689162

Phase 2 Not yet recruiting 45 enrolled Washington University School of Medicine
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to find out which pain medication is more effective in reducing pain after nose surgery (rhinoplasty). The investigators are looking to find the best treatment to reduce discomfort and improve the healing process for patients having nose surgery.

Timeline

Start
2026-07
Primary completion
2027-06
Completion
2027-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.75 % Other
Comparator Bupivacaine Other / unclassified 1.5 ml Other
Comparator Bupivacaine Other / unclassified 2.5 ml Other
Comparator Bupivacaine Other / unclassified 4 ml Other

Indications